| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Magenta Therapeutics, Inc. | Chief People Officer | Common Stock | 20.3K | $243K | $12.00 | Nov 30, 2022 | Direct |
| Magenta Therapeutics, Inc. | Chief People Officer | Stock Option (Right to Buy) | 85K | Aug 1, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| DNTH | Magenta Therapeutics, Inc. | Nov 30, 2022 | 1 | $2.82K | 4 | Dec 2, 2022 | Chief People Officer |
| DNTH | Magenta Therapeutics, Inc. | Aug 1, 2022 | 1 | $0 | 4 | Aug 1, 2022 | Chief People Officer |
| DNTH | Magenta Therapeutics, Inc. | May 31, 2022 | 1 | $2.97K | 4 | Jun 6, 2022 | Chief People Officer |
| DNTH | Magenta Therapeutics, Inc. | May 17, 2022 | 1 | $0 | 4 | May 19, 2022 | Chief People Officer |
| DNTH | Magenta Therapeutics, Inc. | Feb 15, 2022 | 1 | $0 | 4 | Feb 17, 2022 | Chief People Officer |
| DNTH | Magenta Therapeutics, Inc. | Sep 16, 2021 | 1 | -$38.6K | 4 | Sep 20, 2021 | Chief People Officer |
| DNTH | Magenta Therapeutics, Inc. | Sep 14, 2021 | 1 | $0 | 4 | Sep 16, 2021 | Chief People Officer |
| DNTH | Magenta Therapeutics, Inc. | Aug 2, 2021 | 1 | $0 | 4 | Aug 3, 2021 | Chief People Officer |